Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -2.80% | -2.80% | +10.64% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/22/01 |
John Hamill
DFI | Director of Finance/CFO | 60 | 30/23/30 |
Zeev Weiss
PRN | Corporate Officer/Principal | 62 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01/15/01 |
John Henneman
BRD | Director/Board Member | 62 | 01/19/01 |
Rifat Pamukcu
BRD | Director/Board Member | 66 | 01/22/01 |
Jean Bizzari
BRD | Director/Board Member | 69 | 23/23/23 |
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/22/01 |
Marc Duey
BRD | Director/Board Member | 68 | 01/22/01 |
Richard Peters
CHM | Chairman | 61 | 30/20/30 |
Director/Board Member | 70 | 01/22/01 | |
Gabriela Gruia
BRD | Director/Board Member | 67 | 05/23/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 56,227 | 0 | 0 | 83.50 % |
Stock B | 1 | 5,430,215 | 4,534,187 ( 83.50 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.64% | 28.24M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- APRE Stock
- Company Aprea Therapeutics, Inc.